» Articles » PMID: 34452994

The N Terminus of α-synuclein Dictates Fibril Formation

Overview
Specialty Science
Date 2021 Aug 28
PMID 34452994
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The generation of α-synuclein (α-syn) truncations from incomplete proteolysis plays a significant role in the pathogenesis of Parkinson's disease. It is well established that C-terminal truncations exhibit accelerated aggregation and serve as potent seeds in fibril propagation. In contrast, mechanistic understanding of N-terminal truncations remains ill defined. Previously, we found that disease-related C-terminal truncations resulted in increased fibrillar twist, accompanied by modest conformational changes in a more compact core, suggesting that the N-terminal region could be dictating fibril structure. Here, we examined three N-terminal truncations, in which deletions of 13-, 35-, and 40-residues in the N terminus modulated both aggregation kinetics and fibril morphologies. Cross-seeding experiments showed that out of the three variants, only ΔN13-α-syn (14‒140) fibrils were capable of accelerating full-length fibril formation, albeit slower than self-seeding. Interestingly, the reversed cross-seeding reactions with full-length seeds efficiently promoted all but ΔN40-α-syn (41-140). This behavior can be explained by the unique fibril structure that is adopted by 41-140 with two asymmetric protofilaments, which was determined by cryogenic electron microscopy. One protofilament resembles the previously characterized bent β-arch kernel, comprised of residues E46‒K96, whereas in the other protofilament, fewer residues (E61‒D98) are found, adopting an extended β-hairpin conformation that does not resemble other reported structures. An interfilament interface exists between residues K60‒F94 and Q62‒I88 with an intermolecular salt bridge between K80 and E83. Together, these results demonstrate a vital role for the N-terminal residues in α-syn fibril formation and structure, offering insights into the interplay of α-syn and its truncations.

Citing Articles

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation.

Taguchi K, Watanabe Y, Tanaka M iScience. 2025; 28(2):111935.

PMID: 40028275 PMC: 11869972. DOI: 10.1016/j.isci.2025.111935.


Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.

Wiseman J, Turner C, Faull R, Halliday G, Dieriks B Transl Neurodegener. 2025; 14(1):7.

PMID: 39920796 PMC: 11804046. DOI: 10.1186/s40035-025-00469-6.


Positron emission tomography tracers for synucleinopathies.

Xiang J, Zhang Z, Wu S, Ye K Mol Neurodegener. 2025; 20(1):1.

PMID: 39757220 PMC: 11702101. DOI: 10.1186/s13024-024-00787-9.


Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.

Sokratian A, Zhou Y, Tatli M, Burbidge K, Xu E, Viverette E Sci Adv. 2024; 10(44):eadq3539.

PMID: 39485845 PMC: 11800946. DOI: 10.1126/sciadv.adq3539.


On the pH-dependence of α-synuclein amyloid polymorphism and the role of secondary nucleation in seed-based amyloid propagation.

Frey L, Ghosh D, Qureshi B, Rhyner D, Guerrero-Ferreira R, Pokharna A Elife. 2024; 12.

PMID: 39196271 PMC: 11357353. DOI: 10.7554/eLife.93562.


References
1.
Terada M, Suzuki G, Nonaka T, Kametani F, Tamaoka A, Hasegawa M . The effect of truncation on prion-like properties of α-synuclein. J Biol Chem. 2018; 293(36):13910-13920. PMC: 6130941. DOI: 10.1074/jbc.RA118.001862. View

2.
Ni X, McGlinchey R, Jiang J, Lee J . Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations. J Mol Biol. 2019; 431(19):3913-3919. PMC: 6733637. DOI: 10.1016/j.jmb.2019.07.001. View

3.
McGlinchey R, Lacy S, Huffer K, Tayebi N, Sidransky E, Lee J . C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease. J Biol Chem. 2019; 294(25):9973-9984. PMC: 6597809. DOI: 10.1074/jbc.RA119.008930. View

4.
Sorrentino Z, Giasson B . The emerging role of α-synuclein truncation in aggregation and disease. J Biol Chem. 2020; 295(30):10224-10244. PMC: 7383394. DOI: 10.1074/jbc.REV120.011743. View

5.
Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M . Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 1998; 96(5):445-52. DOI: 10.1007/s004010050918. View